Writing the Future of Biologics with Synthetic DNA and Machine Learning

View the Webinar

Presented by

Aaron Sato, PhD

Twist Bioscience

RECORDED AT AET US 2022

Covered in this Webinar

Hear how Twist uses our libraries coupled with Machine Learning

Learn more about the latest innovations in antibody discovery and optimization

Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody discovery libraries including both (1) highly diverse synthetic naïve antibody phage display libraries and (2) target class specific antibody phage display libraries against difficult-to-drug targets. In this talk, Aaron Sato, CSO, will present on how Twist uses our libraries coupled with Machine Learning to discover 1) antibody sequences from NGS sequencing of our successive panning rounds and 2) optimize existing leads derived from traditional screening.

Share your details to Watch the Webinar

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Writing the Future of Biologics with Synthetic DNA and Machine Learning

Related Resources

Improving Cell Therapies with High-throughput CAR Libraries

Synthetic DNA Technologies Enable the Discovery of G Protein-Coupled Receptor Antibody Ligands

High-Throughput Antibody Characterization Services